Nail Fungus (Onychomycosis) Treatment in New Braunfels, TX

Nail fungus treatment New Braunfels TX options have improved significantly — offering real relief to patients living with the embarrassment and discomfort of thickened, yellowed, crumbling nails. Onychomycosis affects approximately 10% of the general population and becomes increasingly prevalent with age. Despite how common it is, many patients don’t realize that professional dermatologic treatment can be highly effective where over-the-counter products consistently fail. At Elect Dermatology, we provide comprehensive nail fungus evaluation and access to multiple treatment options tailored to your specific situation.

What Is Nail Fungus (Onychomycosis)?

Onychomycosis develops when fungal organisms infect the nail plate, the nail bed (tissue beneath the nail), or both. The infection causes the nail to become thick, discolored (typically yellow, brown, or white), brittle, and prone to crumbling or separating from the nail bed. The fungi feed on keratin — the protein that makes up nail tissue — and progressively degrade its structure.

According to the American Academy of Dermatology, onychomycosis accounts for approximately 50% of all nail disorders and is the most common nail disease seen in clinical practice. Toenails are affected roughly four to seven times more often than fingernails. Per a comprehensive review by Lipner and Scher (J Am Acad Dermatol, 2019), onychomycosis affects up to 13% of the population in some studies and poses a significant quality-of-life burden.

Nail fungus is primarily spread through autoinoculation — from one nail to another on the same person. Transmission to other individuals is possible but less common than often feared, typically requiring prolonged shared contact with contaminated surfaces. This distinction matters when counseling patients on prevention.

Types of Onychomycosis

The causative organism affects both the clinical presentation and the treatment response:

Dermatophyte infections: Account for 80–90% of cases. Trichophyton rubrum is the most common organism worldwide. Dermatophytes infect keratin-containing tissue and typically enter at the distal nail tip, progressing proximally toward the cuticle. They respond well to terbinafine and itraconazole.

Candida infections: More common in people with chronic moisture exposure, chronic paronychia, or immunocompromised states. Candida onychomycosis often involves the nail fold and lateral nail edges rather than the distal tip. Treatment response differs from dermatophyte infections.

Non-dermatophyte molds: Less common, accounting for a small minority of cases. These organisms may be less responsive to standard terbinafine therapy, making organism identification through laboratory testing particularly important when non-dermatophyte molds are suspected.

Because different organisms require different treatment strategies, laboratory confirmation (KOH preparation or culture) is often recommended before initiating systemic therapy — particularly when oral antifungals are being prescribed.

Risk Factors for Nail Fungus

Warm, moist environments: Fungi thrive in humid conditions. Locker rooms, public pools, and communal showers are common transmission environments. Tight, moisture-trapping footwear creates an ideal habitat on the foot.

Nail trauma: Any injury that compromises the nail barrier — sports microtrauma, tight shoes, aggressive trimming — allows fungal entry and significantly increases risk.

Immunosuppression: Patients on immunosuppressive medications, living with HIV, or undergoing chemotherapy are at substantially higher risk for fungal infections of all types.

Diabetes mellitus: Altered immunity, peripheral neuropathy, and reduced circulation create a favorable environment for fungal colonization. Patients with diabetes are twice as likely to develop onychomycosis.

Advanced age: Nails become thicker and grow more slowly with age. Reduced peripheral circulation impairs immune response in nail tissue. The prevalence of onychomycosis rises sharply in patients over 60.

Family history: Genetic susceptibility to fungal infection is well documented and likely relates to variations in innate immune response.

Why Over-the-Counter Products Usually Fail

Many patients spend months applying OTC topicals before seeing a dermatologist, with consistently poor results. The reasons are structural:

Penetration barrier: The nail plate is a dense, compact keratin structure that prevents most topical agents from reaching therapeutic concentrations in the infected nail bed. Even purpose-formulated prescription topicals achieve limited penetration compared to systemic therapy.

Treatment duration: Complete cure requires replacement of the entire infected nail with healthy nail — a process that takes 9–12 months for toenails (which grow approximately 1–1.5 mm per month) and 4–6 months for fingernails. Most patients abandon OTC treatment long before reaching this endpoint, allowing the infection to persist.

Low cure rates: Clinical studies consistently show complete cure rates of 5–10% with OTC products, compared to 70–80%+ with appropriately prescribed oral antifungals. Per Lipner and Scher, topical monotherapy is generally reserved for mild-to-moderate distal lateral subungual onychomycosis without matrix involvement.

Nail Fungus Treatment Options

Oral antifungal medications (first-line for most cases): Systemic antifungals achieve therapeutic drug levels in the nail through the bloodstream — bypassing the penetration problem entirely. Terbinafine (Lamisil) is the most effective agent for dermatophyte onychomycosis, with mycologic cure rates of 70–80% and complete cure rates of approximately 35–50% in clinical trials. It is typically prescribed for 6 weeks (fingernails) or 12 weeks (toenails). Itraconazole (Sporanox) is an alternative, often used for Candida or mixed-organism infections, typically given as pulse dosing (1 week per month for 3–4 months).

Baseline liver function testing is recommended for patients with risk factors for hepatotoxicity. Routine monitoring in healthy patients without risk factors is not uniformly required per current guidelines, though practices vary. Your dermatologist will assess your individual situation.

Prescription topical antifungals: Efinaconazole (Jublia) and ciclopirox (Penlac) offer improved nail penetration compared to OTC products. Cure rates are lower than oral therapy but are appropriate for patients with contraindications to systemic treatment or for mild-to-moderate cases. Daily application for 12–48 weeks is typically required.

Combination therapy: Oral plus prescription topical treatment offers complementary mechanisms and improved efficacy compared to either modality alone. A Cochrane systematic review on antifungal treatments for toenail onychomycosis supports combined approaches for optimal outcomes.

Nail debridement: Physical removal of infected nail tissue (by filing or by a clinician) reduces fungal load and improves topical medication contact with the nail bed. Often combined with antifungal therapy.

Laser therapy: Multiple FDA-cleared laser systems target onychomycosis. However, evidence for efficacy is variable and often limited by small study sizes and inconsistent outcome definitions. Laser may serve as an adjunct in refractory cases but is not recommended as standalone therapy per current guidelines.

What to Expect During Treatment

• Weeks 4–8: The infection typically stops progressing; existing infected nail remains but new growth may begin appearing healthy
• Weeks 8–16: Clear, healthy nail growth becomes visible at the cuticle as the nail grows forward
• Months 4–6: Significant visible improvement as healthy nail replaces infected nail
• Months 9–12: Full clearance in responding cases as the entire nail plate is replaced

Recurrence is a real risk — studies suggest 20–25% of patients experience recurrence within 2–3 years after successful treatment. Ongoing prevention practices and prompt re-treatment of early signs are important.

Preventing Nail Fungus Recurrence

• Dry feet thoroughly after bathing; keep nails dry throughout the day
• Wear breathable footwear; alternate shoes to allow drying time
• Use antifungal powder or spray in shoes if you perspire heavily
• Wear shower shoes in public locker rooms and pool areas
• Trim nails straight across and keep them short; avoid trauma
• Use sterilized nail care tools; avoid salon instruments that may not be properly disinfected
• Treat athlete’s foot promptly — tinea pedis is a reservoir for nail reinfection

Frequently Asked Questions: Nail Fungus in New Braunfels

Q: Do I definitely have nail fungus, or could it be something else?
Not all nail discoloration or thickening is fungal — psoriasis, lichen planus, trauma, and other conditions can mimic onychomycosis. A dermatologist can confirm the diagnosis through clinical examination and laboratory testing before prescribing antifungal therapy.

Q: Is oral terbinafine safe?
Terbinafine is well tolerated in the vast majority of patients. Serious hepatotoxicity is rare (estimated 1 in 45,000–120,000 patients). Your dermatologist will review your medication list and medical history to identify any relevant interactions or contraindications before prescribing.

Q: Can I keep going to nail salons during treatment?
It is generally advisable to pause nail salon visits during active treatment. Salon instruments that are not properly sterilized can harbor fungus and potentially reinfect the treated nail.

Q: Will my nail look normal again after treatment?
Most patients see significant improvement, but nail appearance after treatment varies. If the nail matrix (growth center) has been damaged by prolonged infection, some permanent nail changes may remain even after fungal eradication.

References

1. Lipner SR, Scher RK. Onychomycosis: treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853–867. PubMed
2. Gupta AK, et al. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020;34(9):1972–1990. PubMed
3. Cochrane review: antifungal treatments for toenail onychomycosis. PubMed (Cochrane Database Syst Rev. 2017)
4. American Academy of Dermatology. Nail fungus: diagnosis and treatment. AAD.org
5. FDA. Lamisil (terbinafine) product information. FDA.gov

Struggling with thick, discolored nails that haven’t improved with OTC treatment? The board-certified dermatologists at Elect Dermatology in New Braunfels offer confirmatory testing and the full spectrum of treatment options — from prescription topicals to oral antifungals — tailored to your specific organism and nail involvement. Don’t let nail fungus limit your confidence. Call (833) 353-2875 or visit us at 2154 Gabriels Pl, Ste 103, New Braunfels, TX 78130. Healthy nails are achievable with the right plan.

Reviewed by Dr. Hockley

Related Reading

• Fungal Skin Infection Treatment in New Braunfels: Why Texas Heat Makes These Infections Worse
• Seborrheic Dermatitis Treatment: Prescription Options Beyond Dandruff Shampoo
• How Often Should You See a Dermatologist? A New Braunfels Guide
• Medical Dermatology at Elect Dermatology